Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The US Oncology Network
Irving, Texas, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The US Oncology Network empowers over 3,200 providers at more than 700 cancer treatment centers in the US, supporting local delivery of advanced, integrated, and often value-based cancer care. Its network engages in clinical research, contributing to over 70 FDA cancer therapy approvals, and offers broad access to clinical trials and innovative treatments, with more than 1.4 million patients treated annually.[1][4][6][7]
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibodyBiologicRadiation therapyDeviceCell therapy
- Industry
- Non-Academic Healthcare
02
Partnerships
Sarah Cannon Research InstituteOntadaMcKesson
Beyond the preview
Go deeper on The US Oncology Network.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The US Oncology Network.